Idiopathic pulmonary fibrosis (IPF) is a chronic disease in which healthy lung tissue is gradually replaced by scar tissue.
Existing IPF treatments, including Boehringer’s recently approved Jascayd, slow disease progress rather than halt or reverse fibrosis and its effect on lung function. A drug that resolves fibrosis ...
Woman's World on MSN
The early warning signs of COPD you need to know—and how it differs from bronchitis
When you think about diseases that affect the lungs, like chronic obstructive pulmonary disease (COPD), there are likely some ...
When Amy was first diagnosed with scleroderma, she never imagined it would lead to a lifelong journey with lung disease.
Good medical care is essential for patients with idiopathic pulmonary fibrosis. But navigating daily life with the disease ...
FDA has granted orphan drug designation to FS2 (kynurenic acid) for the investigational treatment of idiopathic pulmonary ...
Using coronary artery calcium scores alongside cardiovascular risk scores better identifies patients with chronic obstructive pulmonary disease at a high risk for major adverse cardiovascular events.
What Is Pulmonary Vascular Disease? The definition of pulmonary vascular disease is simple: any condition that affects the blood vessels along the route between the heart and lungs. Blood travels from ...
The Department of Anesthesiology and Intensive Care Medicine at the Carl Gustav Carus University Hospital in Dresden and the ...
Pulmonary fibrosis is a condition that causes lung scarring and stiffness. This makes it difficult to breathe. It can prevent your body from getting enough oxygen and may eventually lead to ...
Researchers from the University of Windsor are using neutrons at the Department of Energy's Oak Ridge National Laboratory to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback